- Home
- SBFG vs ACHV Comparison
SBFG vs ACHV Comparison
Compare SBFG & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFG
- ACHV
- Stock Information
- Founded
- SBFG 1983
- ACHV N/A
- Country
- SBFG United States
- ACHV Canada
- Employees
- SBFG N/A
- ACHV N/A
- Industry
- SBFG Major Banks
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SBFG Finance
- ACHV Health Care
- Exchange
- SBFG Nasdaq
- ACHV Nasdaq
- Market Cap
- SBFG 155.9M
- ACHV 126.9M
- IPO Year
- SBFG N/A
- ACHV N/A
- Fundamental
- Price
- SBFG $22.08
- ACHV $3.17
- Analyst Decision
- SBFG
- ACHV Strong Buy
- Analyst Count
- SBFG 0
- ACHV 5
- Target Price
- SBFG N/A
- ACHV $14.80
- AVG Volume (30 Days)
- SBFG 14.9K
- ACHV 229.0K
- Earning Date
- SBFG 04-17-2025
- ACHV 03-27-2025
- Dividend Yield
- SBFG 2.63%
- ACHV N/A
- EPS Growth
- SBFG N/A
- ACHV N/A
- EPS
- SBFG 1.72
- ACHV N/A
- Revenue
- SBFG $56,772,000.00
- ACHV N/A
- Revenue This Year
- SBFG N/A
- ACHV N/A
- Revenue Next Year
- SBFG N/A
- ACHV N/A
- P/E Ratio
- SBFG $12.84
- ACHV N/A
- Revenue Growth
- SBFG 0.08
- ACHV N/A
- 52 Week Low
- SBFG $13.01
- ACHV $2.84
- 52 Week High
- SBFG $24.48
- ACHV $5.59
- Technical
- Relative Strength Index (RSI)
- SBFG 44.16
- ACHV 44.06
- Support Level
- SBFG $23.00
- ACHV $3.18
- Resistance Level
- SBFG $24.22
- ACHV $3.59
- Average True Range (ATR)
- SBFG 0.97
- ACHV 0.21
- MACD
- SBFG -0.18
- ACHV 0.01
- Stochastic Oscillator
- SBFG 31.03
- ACHV 19.48
About SBFG SB Financial Group Inc.
SB Financial Group Inc operates as a Holding Company of State Bank and RDSI/DCM. Its activities involve commercial banking, trust, and financial services. It offers a full-range of financial services for consumers and small businesses, including trust services, mortgage banking, wealth management services, commercial and agricultural lending. It accepts deposits, such as checking accounts, savings accounts, money market accounts, demand deposits, and time certificates of deposit. It earns revenue in the form of interest income.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.